XenoPort Reports Feedback from FDA on XP23829
January 12, 2014 at 17:20 PM EST
XenoPort (NASDAQ: XNPT ) today reported an update on XP23289 development, including feedback from the U.S. Food and Drug Administration (FDA) on the potential development plans, and XenoPort's progress on